Drug Shortage Report for PENTAMIDINE ISETIONATE FOR INJECTION BP
Report ID | 43643 |
Drug Identification Number | 02183080 |
Brand name | PENTAMIDINE ISETIONATE FOR INJECTION BP |
Common or Proper name | PENTAMIDINE ISETIONATE |
Company Name | PFIZER CANADA ULC |
Market Status | MARKETED |
Active Ingredient(s) | PENTAMIDINE ISETIONATE |
Strength(s) | 300MG |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAMUSCULAR INTRAVENOUS |
Packaging size | 5 x 300mg GVL |
ATC code | P01CX |
ATC description | AGENTS AGAINST LEISHMANIASIS AND TRYPANOSOMIASIS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2018-03-26 |
Actual start date | |
Estimated end date | |
Actual end date | 2018-04-19 |
Shortage status | Resolved |
Updated date | 2018-04-20 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2018-03-21 | English | Compare |
v2 | 2018-03-21 | French | Compare |
v3 | 2018-03-27 | English | Compare |
v4 | 2018-04-04 | English | Compare |
v5 | 2018-04-04 | French | Compare |
v6 | 2018-04-19 | English | Compare |
v7 | 2018-04-19 | French | Compare |
v8 | 2018-04-20 | English | Compare |
Showing 1 to 8 of 8